---
$id: https://graph.org.ai/products/commodity/51141565
$type: Product
source: UNSPSC
code: "51141565"
title: "Losigamone"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Losigamone

**UNSPSC Code**: 51141565
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C12H11ClO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 84R8O3QM2G, chemically known as 2(5h)-furanone, 5-((2-chlorophenyl)hydroxymethyl)-4-methoxy-, (r*,s*)- but generally known as losigamone, which bears US NIH Compound Identifier 60572. European Medicines Agency schedules Losigamone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08594MIG. The term LOSIGAMONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). LOSIGAMONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, LOSIGAMONE remains the US FDA Preferred Term for this commodity. Losigamone bears US NLM identifiers UMLS ID C0083259 and NCI Concept Code C90707. SMILES: COC1=CC(=O)OC1C(C2=CC=CC=C2CL)O.

